CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Sales | ₹1,196 Cr | ₹10,145 Cr | ₹884 Cr | ₹884 Cr |
What is the latest Revenue of CORONA REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,196 Cr |
| Mar2025 | ₹10,145 Cr |
| Mar2024 | ₹884 Cr |
| Mar2023 | ₹884 Cr |
How is Revenue of CORONA REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,196 Cr | -88.21 | |
| Mar2025 | ₹10,145 Cr | 1,047.53 | |
| Mar2024 | ₹884 Cr | 0.00 | |
| Mar2023 | ₹884 Cr | - | |
Compare Revenue of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,087.6 Cr | -1.7% | 13.7% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -1.7% |
13.7% |
|
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses